These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 31400353
1. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma. Soares CD, de Lima Morais TM, Carlos R, Martins MD, de Almeida OP, Mariano FV, Altemani A. Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353 [Abstract] [Full Text] [Related]
2. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH. Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480 [Abstract] [Full Text] [Related]
3. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma. Griffith CC, Thompson LD, Assaad A, Purgina BM, Lai C, Bauman JE, Weinreb I, Seethala RR, Chiosea SI. Histopathology; 2014 Dec; 65(6):854-60. PubMed ID: 24804831 [Abstract] [Full Text] [Related]
4. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I. Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717 [Abstract] [Full Text] [Related]
5. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE. Cancer; 2016 Oct 15; 122(20):3136-3144. PubMed ID: 27379604 [Abstract] [Full Text] [Related]
6. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF. Histopathology; 2017 Oct 15; 71(4):511-521. PubMed ID: 28463429 [Abstract] [Full Text] [Related]
7. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases. Bahrami A, Dalton JD, Shivakumar B, Krane JF. Head Neck Pathol; 2012 Sep 15; 6(3):328-35. PubMed ID: 22485045 [Abstract] [Full Text] [Related]
8. Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness. Moriwaki K, Ayani Y, Kuwabara H, Terada T, Higashino M, Kawata R. Oral Oncol; 2024 Apr 15; 151():106751. PubMed ID: 38479153 [Abstract] [Full Text] [Related]
9. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma. Kondo Y, Hirabayashi K, Carreras J, Tsukinoki K, Ota Y, Okami K, Nakamura N. Ann Diagn Pathol; 2021 Feb 15; 50():151673. PubMed ID: 33248386 [Abstract] [Full Text] [Related]
14. Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma. Silva LP, Santana T, Sedassari BT, de Sousa SM, Sobral APV, Freitas RA, Barboza CAG, de Souza LB. Eur Arch Otorhinolaryngol; 2017 Aug 15; 274(8):3203-3209. PubMed ID: 28523411 [Abstract] [Full Text] [Related]
15. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome. Sedassari BT, Rodrigues MFSD, Conceição TS, Mariano FV, Alves VAF, Nunes FD, Altemani A, de Sousa SCOM. Virchows Arch; 2017 Dec 15; 471(6):775-784. PubMed ID: 28842747 [Abstract] [Full Text] [Related]
16. Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis. Kusafuka K, Kawasaki T, Onitsuka T, Hamaguchi N, Morita K, Mukaigawa T, Nishiya Y, Kamijo T, Iida Y, Nakajima T, Sugino T. Head Neck Pathol; 2020 Mar 15; 14(1):230-238. PubMed ID: 30484070 [Abstract] [Full Text] [Related]